or Try an Advanced Search...

    Luvox Cr Stocks List

    Symbol Grade Name % Change
    ALKS F Alkermes plc 0.21
    JAZZ D Jazz Pharmaceuticals plc -0.15
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Obsessive Compulsive Disorder Pain Schizophrenia Acute Lymphoblastic Leukemia Alcohol Angina Antibiotics Asparaginase Atypical Antipsychotics Biotechnology Bone Cachexia Cancer Cataplexy Chemotherapy Cholesterol Chronic Pain Clinical Medicine Cocaine

    Related ETFs - A few ETFs which own one or more of the above listed Luvox Cr stocks.

    Symbol Grade Name Weight
    TOKE B Cambria Cannabis ETF 4.7
    XPH D SPDR S&P Pharmaceuticals ETF 4.61
    PSIL F AdvisorShares Psychedelics ETF 4.48
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 4.1
    PILL F Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 3.81
    View all Luvox Cr ETFs...
    Compare ETFs
    Compare PSIL to FTXH Compare TOKE to PILL Compare XPH to PILL

        Luvox Cr Stocks Recent News

        Date Stock Title
        May 6 JAZZ Jazz (JAZZ) International Revenue Performance Explored
        May 3 JAZZ Jazz Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
        May 2 ALKS Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
        May 2 ALKS Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk
        May 2 JAZZ Jazz Pharmaceuticals plc (JAZZ) Q1 2024 Earnings Call Transcript
        May 1 JAZZ Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
        May 1 JAZZ Jazz Pharmaceuticals plc 2024 Q1 - Results - Earnings Call Presentation
        May 1 JAZZ Jazz Pharmaceuticals misses top-line and bottom-line estimates; reaffirms FY24 outlook
        May 1 JAZZ Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
        May 1 JAZZ Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
        May 1 ALKS Alkermes plc (ALKS) Q1 2024 Earnings Call Transcript
        May 1 ALKS Alkermes plc 2024 Q1 - Results - Earnings Call Presentation
        May 1 ALKS Alkermes (ALKS) Reports Q1 Earnings: What Key Metrics Have to Say
        May 1 ALKS Alkermes (ALKS) Q1 Earnings and Revenues Miss Estimates
        May 1 ALKS Alkermes Non-GAAP EPS of $0.43 misses by $0.15, revenue of $350.4M misses by $9.87M
        May 1 ALKS Alkermes plc Reports First Quarter 2024 Financial Results
        Apr 30 JAZZ Jazz Pharmaceuticals Q1 2024 Earnings Preview
        Apr 30 ALKS Alkermes Q1 2024 Earnings Preview
        Apr 30 ALKS How To Trade Biotech Stocks: Can These Three Tips Help You Make More Profits?
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Obsessive Compulsive Disorder Pain Schizophrenia Acute Lymphoblastic Leukemia Alcohol Angina Antibiotics Asparaginase Atypical Antipsychotics Biotechnology Bone Cachexia Cancer Cataplexy Chemotherapy Cholesterol Chronic Pain Clinical Medicine Cocaine
        Luvox Cr

        Luvox CR (fluvoxamine) is an antidepressant medication used to treat obsessive-compulsive disorder (OCD). It is in a class of medications called selective serotonin reuptake inhibitors (SSRIs). Luvox CR works by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.

        Browse All Tags